一、主要学术成就：        攻关精神分裂症风险早识别和早干预的关键技术，开展应用基础研究，取得系列原创性成果并临床应用。以第一或通讯作者(含共同) 在 Am J Psychiatry、JAMA Netw Open、Brain Stimul、Schizophr Bull 等领域高水平期刊发表 SCI 论文 60 余篇;主持科技创新 2030-脑科学与类脑研究重大项目青年科学家项目、国家自然科学基 金项目(3 项) 、上海市自然科学基金原创探索项目(并获滚动资助);关键技术创新获得专利授权 5 项，在多家精神科专科医院示范应用累计超过10000人次；“精神病性障碍超早期精准诊疗技术体系创建和转化应用”获得华夏医学科技奖三等奖，获得春昇杯”医学创新人才大赛二等奖；入选上海市青年拔尖人才计划、上海交通大学医学院高峰学科-临床医学 “临床专职科研队伍”( 并获滚动资助)、上海市卫生计生系统优秀青年人才培养计划等。 二、代表性论著：    [1] Chen S*, Sheng J#, Yang F, Qiao Y, Wang W, Wen H, Yang Q, Chen X, Tang Y# (2024)：Magnetic Seizure Therapy vs Modified Electroconvulsive Therapy in Patients With Bipolar Mania: A Randomized Clinical Trial, JAMA Netw Open 7(4):e247919.    [2] Tang Y*, Pasternak O*,#, Kubicki M, Rathi Y, Zhang T, Wang J, Li H, Woodberry KA, Xu L., Qian Z, Zhu A, Whitfield-Gabrieli S, Keshavan MS, Niznikiewicz M, Stone WS, McCarley RW, Shenton ME, Wang J#, Seidman LJ (2019): Altered Cellular White Matter But Not Extracellular Free Water on Diffusion MRI in Individuals at Clinical High Risk for Psychosis, Am J Psychiatry 176(10):820-828.    [3] Tang Y*, Xu L*, Zhu T, Cui H, Qian Z, Kong G, Tang X, Wei Y, Zhang T, Hu Y, Sheng J, Wang J# (2023): Visuospatial Learning Selectively Enhanced by Personalized Transcranial Magnetic Stimulation over Parieto-Hippocampal Network among Patients at Clinical High-Risk for Psychosis, Schizophr Bull 49:923-932.    [4] Wu G*, Zhu T*, Ma C*, Xu L, Qian Z, Kong G, Cui H, Zhang T, Wang J#, Tang Y# (2025): Association of Abnormal Cortical Inhibition and Clinical Outcomes in Patients at Clinical High Risk for Psychosis, Clinical Neurophysiology 169: 65-73.    [5] Kong G*, Wei L, Wang J, Zhu C#, Tang Y# (2022), The therapeutic potential of personalized connectivity-guided transcranial magnetic stimulation target over group-average target for depression, Brain Stimul, 15(5):1063-1064.    [6] Cai Y*, Jin Z, Zhai C, Wang H, Wang J, Tang Y#, Kwok SC# (2022): Time-sensitive prefrontal involvement in associating confidence with task performance illustrates metacognitive introspection in monkeys, Commun Biol, 5(1), 799. doi:10.1038/s42003-022-03762-6.    [7] Tang Y*, Wang J, Zhang T, Xu L, Qian Z, Cui H, Tang X, Li H, Whitfield-Gabrieli S, Shenton ME, Seidman LJ, McCarley RW, Keshavan MS, Stone WS, Wang J#, Niznikiewicz MA (2020): P300 as an index of transition to psychosis and of remission: Data from a clinical high risk for psychosis study and review of literature, Schizophr Res, 226:74-83.    [8] Wang J*, Tang Y*,#, Curtin A, Xia M, Tang X, Zhao Y, Li Y, Qian Z, Sheng J, Zhang T, Jia Y, Li C, Wang J#. (2019): ECT-induced brain plasticity correlates with positive symptom improvement in schizophrenia by voxel-based morphometry analysis of grey matter. Brain Stimulation 12: 319-328.    [9] Zhang T*,#, Zhu J*, Xu L, Tang X, Cui H, Wei Y, Wang Y, Hu Q, Qian Z, Liu X, Tang Y#, Li C, Wang J#. (2019): Add-on rTMS for the acute treatment of depressive symptoms is probably more effective in adolescents than in adults: Evidence from real-world clinical practice. Brain Stimulation 12: 103-109.